Early Signal

real-time and individualized disease monitoring is central to rapidly evolving medical sciences and technologies, but for the vast majority of patients, disease progression and treatment are currently being monitored only in an irregular and discontinuous fashion. consequently, disease progression and relapse are often allowed to proceed too far before they are detected, compromising the possibility of any effective treatment. for the parkinson's patient, this can mean becoming refractory to the few drug treatments that are currently available; for the brain cancer victim, the difference may be between life and death. early signal is a non-profit organization centered on a universal yet personalized health-monitoring solution exploiting the recent profusion of cell phones and other wearable smart devices that generate extensive real-time biometric data for the patient.